study of GZR4 injection at different injection sites
Treatments studied
This trial tests how a single injection of a new drug called GZR4 is absorbed when given at different injection sites (like the belly or thigh) in healthy men. It helps researchers understand how the drug works in the body before testing it in people with diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male and between 18 and 55 years old.
- Your body mass index (BMI) is between 19.0 and 24.0.
- You are not allergic to the study drug or similar products.
- You have not participated in another clinical trial in the last 3 months.
- You drink less than 14 alcoholic drinks per week and smoke fewer than 5 cigarettes daily.
- You have not donated blood or lost a lot of blood in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection (GZR102) compared to two other injections (GZR4 and GZR18) in overweight adults. The goal is to see how well the body processes each drug and their effects. It may help researchers find a better treatment for weight management.
This trial tests how a new drug called GZR18 (given as an injection) affects the body in people with different levels of kidney function. It aims to find the right dose and check for side effects, which could help guide treatment for people with kidney issues.
This study tests a new drug called GZR18 to see how it works in people with different levels of liver function. It aims to help find the right dose and check safety.
This study tests a new injectable medication called GZR33 to help control blood sugar in people with type 2 diabetes who are already taking oral diabetes pills. The trial will measure how well it works and how safe it is.
This trial tests how a new injectable drug, GZR18, affects how fast your stomach empties and how it interacts with other medicines. It is for obese Chinese adults who want to join a research study.
This trial compares two once-daily insulin injections to see which works better and is safer for people with type 2 diabetes. Both are new types of insulin designed to help control blood sugar with fewer side effects.
Hear when a new Healthy Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.